Drug Pipeline

JMT108 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07280832 Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant… Unresectable Locally Advanced or Metastatic Melanoma Recruiting
NCT06877650 First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant… Advanced Malignant Tumors Recruiting
Phase 1
NCT07317505 A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors Cancer Recruiting
Sponsors Running JMT108 Trials
Shanghai JMT-Bio Inc. (2) Conjupro Biotherapeutics, Inc. (1)
Disease Areas
Melanoma (1)
Get alerts when JMT108 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free